Antiphospholipid antibodies: A possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders

Journal of Neurology

Volumn 261, Issue 1, 2014, Pages 2028-2029

  Koudriavtseva, Tatiana ^a   Plantone, Domenico ^a   Renna, Rosaria ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY;

BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MYELOOPTIC NEUROPATHY;

ANTIBODIES, ANTICARDIOLIPIN; CARDIOLIPINS; FEMALE; HUMANS; MALE; NEUROMYELITIS OPTICA;

EID: 84914668043     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7506-5     Document Type: Letter

References (16)

1. Iong Y, He Y, Zheng Y, Chen M, Zhang B, Gao C (2013) Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder. J Neurol 260(12):3150-3157
2. Wu L, Huang D, Yang Y, Wu W (2014) Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis. Eur Neurol 72(1-2):103-108
3. Koudriavtseva T, D’Agosto G, Mandoj C, Sperduti I, Cordiali-Fei P (2014) High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes. Neurol Sci. doi:10.1007/s10072-014-1823-4
4. Spadaro M, Amendolea MA, Mazzucconi MG, Fantozzi R, Di Lello R, Zangari P, Masala G (1999) Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler 5(2):121-125
5. Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B (2007) Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol 187(1-2):159-165
6. Bidot CJ, Horstman LL, Jy W, Jimenez JJ, Bidot C Jr, Ahn YS, Alexander JS, Gonzalez-Toledo E, Kelley RE, Minagar A (2007) Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 7:36
7. Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A, Weinstock-Guttman B (2012) Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study. Neurol Res 34(8):761-769. doi:10.1179/1743132812Y.0000000076
8. Brunetti A, Ricchieri GL, Patrassi GM, Girolami A, Tavolato B (1981) Rheological and fibrinolytic findings in multiple sclerosis. J Neurol Neurosurg Psychiatry 44(4):340-343
9. Kirichuk VF, Streknev AG (2003) The role of hemostasis system in the pathogenesis and course of multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova (Spec No 2):34-38
10. Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U (2008) Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci 15(4):393-397. doi:10.1016/j.jocn.2007.02.090
11. Campos-de-Magalhães M, de Almeida AJ, Papaiz-Alvarenga RM, Gadelha T, Morais-de-Sá CA, Alves-Leon SV (2009) Normal plasma antithrombin activity in patients with relapsingremitting and secondary progressive multiple sclerosis. Clin Neurol Neurosurg 111(5):407-411. doi:10.1016/j.clineuro.2008.11.016
12. Ingram G, Hakobyan S, Hirst CL, Harris CL, Loveless S, Mitchell JP, Pickersgill TP, Robertson NP, Morgan BP (2012) Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Mult Scler 18(10):1401-1411
13. Festoff BW, Li C, Woodhams B, Lynch S (2012) Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication. J Neurol Sci 323(1-2):61-65. doi:10.1016/j.jns.2012.08.008
14. Koudriavtseva T (2014) Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Front Neurol 5:119. doi:10.3389/fneur.2014.00119
15. Renaud M, Aupy J, Uring-Lambert B, Chanson JB, Collongues N, Blanc F, De Sèze J (2014) Isolated anti-b2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome? Eur J Neurol 21(6):901-906. doi:10.1111/ene.12408
16. Sastre-Garriga Reverter JC, Font J, Tintoré M, Espinosa G, Montalban X (2001) Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 49(3):408-411